Targeted Therapy and Biomarkers for Solid Tumors
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Mechanisms of Diseases".
Deadline for manuscript submissions: 20 April 2025 | Viewed by 125
Special Issue Editors
Interests: oncology; cancer immunology; oncology radiotherapy; solid tumors
Special Issue Information
Dear Colleagues,
The management of solid tumors has evolved significantly with the advent of targeted therapies and the identification of biomarkers. These advancements have allowed for more precise treatment modalities that improve patient outcomes and reduce adverse effects.
Targeted therapy emerged in the late 20th century, revolutionizing cancer treatment by focusing on specific molecular targets associated with cancer growth and progression. The discovery and validation of biomarkers have been pivotal in tailoring these therapies to individual patients.
This Special Issue aims to explore the latest developments in targeted therapies and biomarker research for solid tumors. It seeks to highlight innovative approaches, from molecular mechanisms to clinical applications, that contribute to personalized cancer treatment.
We are interested in research that delves into the discovery of novel biomarkers, mechanisms of resistance to targeted therapies, and the development of new therapeutic agents. Studies that integrate multi-omics data and translational research are particularly encouraged.
We welcome original research articles and comprehensive reviews that address any aspect of targeted therapy and biomarker discovery in solid tumors. Submissions focusing on clinical trials, mechanistic studies, and technological advancements in this field are highly valued.
Dr. Anca Zgură
Prof. Dr. Rodica Maricela Anghel
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- targeted therapy
- biomarkers
- solid tumors
- oncology
- cancer immunology
- oncology radiotherapy
- personalized medicine
- molecular targets
- drug resistance
- translational research
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
